토끼에서 αvβ5 인테그린 항체의 결막하주사에 의한 각막신생혈관 억제효과

• 영문명: Inhibition of Corneal Neovascularization by Subconjunctival Injection of αvβ5 Integrin Antibody in Rabbit
• 발행기관: 대한안과학회
• 저자명: 윤경철 임성규 오한진 안규윤 김경근,Kyung-Chul Yoon, M.D., Seong-Kyu Im, M.D., Han-Jin Oh, M.D., Kyu-Youn Ahn, M.D., Kyung-Keun Kim, M.D.
• 간행물 정보: 『대한안과학회지』Ophthalmological Society,volume46,number11, 1863~1870쪽, 전체 8쪽
• 주제분류: 의약학 > 기타의약학
• 파일형태: PDF
• 발행일자: 2005.11.30

영문 초록

Purpose: To investigate the efficacy of a subconjunctival injection of αvβ5 integrin antibody on corneal angiogenesis induced by chemical epithelial denudation in a rabbit eye model. Methods: One week after debridement by heptanol, rabbits were treated with a subconjunctival injection of αvβ5 integrin antibody or control immunoglobulin G weekly for 2 weeks. Rabbits that did not receive injection after debridement served as the untreated group. The percentage of neovascularized corneal area was calculated by biomicroscopy, and the sectioned area and number of new vessels were calculated by histological examinations. Results: At 7 days after the first injection, αvβ5 integrin antibody-treated eyes had 9.5% (P=0.02) and 6.8% (P=0.03) less neovascularized corneal area than vector-treated eyes and untreated eyes, respectively. At 7 days after the second injection, αvβ5 integrin antibody-treated eyes had 21.1% (P=0.02) and 18.3% (P=0.02) less neovascularized corneal area than vector-treated eyes and untreated eyes, respectively. Light microscopic examination showed a smaller neovascularized corneal area and a reduced number of new vessels in the αv β5 integrin antibody-treated eyes compared to the control eyes. Conclusions: Subconjunctival injection of αvβ5 integrin antibody effectively reduces experimental corneal neovascularization induced by chemical injury, and could be used as a corneal angiogenesis inhibitor in the future.

키워드

Corneal neovascularization, αvαv integrin antibody, Subconjunctival injection